.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
A systematic review of endobronchial ultrasound-guided transbronchial needle aspiration evaluated its diagnostic performance for mediastinal staging in lung cancer. Across the evidence base, EBUS-TBNA showed high specificity and strong sensitivity for detecting mediastinal lymph-node involvement, supporting its role as a minimally invasive alternative to surgical staging in appropriately selected patients. The study is highly relevant to contemporary thoracic oncology because staging accuracy directly influences treatment pathways. When nodal disease can be established through an endoscopic approach, patients may avoid more invasive procedures and move more efficiently toward definitive management. The paper also supports a procedural sequence in which tissue diagnosis and staging are integrated rather than treated as completely separate steps. For HCPs, the practical point is to recognize when EBUS should be considered early in the diagnostic pathway and to understand its limitations, including sampling constraints and the need for adequate procedural expertise. This evidence aligns directly with the conference’s emphasis on EBUS-TBNA as first-line staging and on building multidisciplinary pathways between pulmonology, radiology, oncology, and surgery.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A systematic review of endobronchial ultrasound-guided transbronchial needle aspiration evaluated its diagnostic performance for mediastinal staging in lung cancer. Across the evidence base, EBUS-TBNA showed high specificity and strong sensitivity for detecting mediastinal lymph-node involvement, supporting its role as a minimally invasive alternative to surgical staging in appropriately selected patients. The study is highly relevant to contemporary thoracic oncology because staging accuracy directly influences treatment pathways. When nodal disease can be established through an endoscopic approach, patients may avoid more invasive procedures and move more efficiently toward definitive management. The paper also supports a procedural sequence in which tissue diagnosis and staging are integrated rather than treated as completely separate steps. For HCPs, the practical point is to recognize when EBUS should be considered early in the diagnostic pathway and to understand its limitations, including sampling constraints and the need for adequate procedural expertise. This evidence aligns directly with the conference’s emphasis on EBUS-TBNA as first-line staging and on building multidisciplinary pathways between pulmonology, radiology, oncology, and surgery.
Today
The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
6 days back
A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
3 weeks back
Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
6 days back
A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
3 weeks back
A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
6 days back
